Clincosm LogoSign in Get a demo

Advanced Breast Cancer

Showing 51 - 75 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Durham (Breast Cancer Tumor Resection)

Recruiting
  • Advanced Breast Cancer
  • Breast Cancer Tumor Resection
  • Durham, North Carolina
    Duke University Medical Center
Jul 13, 2022

Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

Active, not recruiting
Has Results
  • Advanced Breast Cancer
  • Beijing, Beijing, China
  • +6 more
Jun 23, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • (no location specified)
Jul 6, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c, Letrozole or anastrozole, Goserelin acetate
  • Placebo, Letrozole or anastrozole, Goserelin acetate
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jul 4, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c,Fulvestrant,Goserelin acetate
  • Placebo,Fulvestrant,Goserelin acetate
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 30, 2022

Advanced Breast Cancer Trial in Beijing (Dalpiciclib in combination with endocrine therapy by Physicians choice)

Not yet recruiting
  • Advanced Breast Cancer
  • Dalpiciclib in combination with endocrine therapy by Physicians choice
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jun 19, 2022

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Advanced Breast Cancer, Advanced Colorectal Cancer, Cancer Rehabilitation Trial (In-person rehabilitaiton group, Virtual

Not yet recruiting
  • Advanced Breast Cancer
  • +2 more
  • In-person rehabilitaiton group
  • Virtual rehabilitation group
  • (no location specified)
Jun 15, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Paris, France
  • +24 more
Jun 7, 2022

Advanced Breast Cancer Trial in Spain (CB-103)

Active, not recruiting
  • Advanced Breast Cancer
  • Alzira, Spain
  • +14 more
Jun 7, 2022

Advanced Breast Cancer Trial in Shanghai (Pegylated Liposomal Doxorubicin)

Recruiting
  • Advanced Breast Cancer
  • Pegylated Liposomal Doxorubicin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Advanced Breast Cancer Trial in Shanghai (GB491+Letrozole)

Recruiting
  • Advanced Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 14, 2022

Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • +7 more
  • Anaheim, California
  • +4 more
Apr 6, 2022

Advanced Breast Cancer, Metastatic Breast Cancer Trial in Tianjin (SHR6390, famitinib)

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
Apr 6, 2022

Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer Trial in Denmark, Finland, France

Active, not recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Copenhagen, Denmark
  • +3 more
Mar 23, 2022

Advanced Breast Cancer Trial in Poland, Turkey (Plasma soluble TNF receptor pulldown, Plasma soluble TNF receptor pulldown +

Recruiting
  • Advanced Breast Cancer
  • Plasma soluble TNF receptor pulldown
  • +2 more
  • Kraków, Małopolskie, Poland
  • +4 more
Mar 9, 2022

Advanced Breast Cancer Trial (SYHX2011 and Abraxane®)

Not yet recruiting
  • Advanced Breast Cancer
  • SYHX2011 and Abraxane®
  • (no location specified)
Mar 2, 2022

Advanced Breast Cancer Trial in Harbin (XZP-3287+ Letrozole/Anastrozole, Placebo + Letrozole/Anastrozole)

Not yet recruiting
  • Advanced Breast Cancer
  • XZP-3287+ Letrozole/Anastrozole
  • Placebo + Letrozole/Anastrozole
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Feb 16, 2022

Advanced Breast Cancer Trial (pyrotinib)

Not yet recruiting
  • Advanced Breast Cancer
  • (no location specified)
Feb 16, 2022

Advanced Breast Cancer, Anxiety, CBD Trial in Boston (Cannabidiol, Placebo)

Recruiting
  • Advanced Breast Cancer
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 2, 2022

Advanced Breast Cancer Trial in Dallas (PD-0332991 and T-DM1)

Completed
  • Advanced Breast Cancer
  • PD-0332991 and T-DM1
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 24, 2022

Advanced Breast Cancer Trial in Italy (Abemaciclib, Aromatase Inhibitors)

Recruiting
  • Advanced Breast Cancer
  • Ancona, Italy
  • +43 more
Jan 31, 2022

Health Care Disparities in Culturally Diverse, Special Needs &

Recruiting
  • Advanced Breast Cancer
    • Jerusalem, Israel
      Hadassah medical Organization
    Jan 23, 2022

    Advanced Breast Cancer Trial in Beijing (XZP-3287+Fulvestrant, Placebo + Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Beijing, Beijing, China
      Chinese Academy of Medical Science
    Jan 4, 2022

    Advanced Breast Cancer Trial in China (RC48-ADC 1.5 mg/kg (HER2 Positive), RC48-ADC 2.0 mg/kg (HER2 Positive), RC48-ADC 2.5

    Active, not recruiting
    • Advanced Breast Cancer
    • RC48-ADC 1.5 mg/kg (HER2 Positive)
    • +3 more
    • Beijing, Beijing, China
    • +3 more
    Jan 7, 2022